Upstream Pharma - UPB Net Assets per Single Share
Upstream Bio Inc (UPB) is creating an ecosystem for the targeted treatment of severe inflammation through unique antibodies, while high testing costs and strict regulatory oversight create significant barriers to entry for competitors. This price chart on GURU.Markets demonstrates the asset's dynamics, with a value of 4.93. The business is focused on completing the final stages of its molecule trials and preparing to bring products to market.
%20Share%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvouo2ve.rkk-7albim8&start=20220704&end=20261026&filename=GURU_Markets_-_UPB_-_Upstream-Bio-Inc_-_Share-Book-Value "UPB Upstream Bio, Inc.: Book Value per Share in the range 10/12/2024 - 10/26/2026 | 👁️GURU.Markets👁️")
upstreambio.com - analytical breakdowns and key metrics (UPB)
Directory of indicators and multiples for Upstream Bio (UPB):
Stock Price Upstream Bio Corp|UPB - Price Target Chart|Market Value Upstream Bio Inc|UPB - Full Business Value|Book Value per Share Upstream Bio|UPB - Accounting Value of Company|Market Capitalization to Book Value Ratio upstreambio.com|UPB - Company Total Assets|Debt to Equity Upstream Bio Inc|UPB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Upstream Bio|UPB - Company Total Debt|Debts to Book Capitalization Upstream Bio Inc
Analysis of all company metrics:Upstream Bio Corp (UPB)
Book value per share reflects the company's net assets divided by the number of outstanding shares, excluding subjective valuations. This indicator reveals the gap between actual capital and strategic objectives. By analyzing book value per share under IFRS, an investor assesses the fundamental protection of their investment. For Upstream Bio Inc (UPB), this metric confirms the financial base that supports the maintenance of an elite staff of immunologists. Resource capitalization directly supports the development of innovative medicines.
Competitor analysis
ARGX - Book Value per Share|BNTX: Net Assets per Single Share|Net Assets per Single Share Abivax Corp (ABVX)|admabiologics.com (ADMA) - Share Book Value|PTGX - Book Value per Share|Accounting Value of a Share Immunovant Inc|Book Value per Share KNSA|Book Value per Share GRFS (Grifols Biemat)|Net Assets per Single Share Adaptive Biotechnologies|celldex.com - Accounting Value of a Share|AUPH: Net Assets per Single Share|BCRX - Accounting Value per Share|VERA: Book Value per Share|Book Value per Share Dianthus Corp|PHVS - Accounting Value per Share|Accounting Value of a Share AbCellera Corp|TRML (Tourmaline Bio) - Book Value per Share|Net Assets per Share PGEN (Precigen Inc)|Pharming - Net Assets per Single Share|Nektar Corp - Accounting Value per Share|ZBIO: Net Assets per Single Share|immunome.com (IMNM) - Accounting Value per Share|GOSS: Accounting Value per Share|KALV (KalVista Pharma) - Book Value per Share|Net Assets per Single Share Septerna Corp (SEPN)|Equity per Share Pieris Corp|Savara Inc. - Book Value per Share|Net Asset Value per Share rigel.com RIGL|Accounting Value per Share ANAB (AnaptysBio)|Astria Therapeutics Inc - Book Value per Share|Net Assets per Single Share enGene Bio|RAPT: Share Book Value|aerovatetx.com - Net Assets per Single Share|Net Assets per Share aclaristx.com|Kyverna Therapeutics, Inc. (KYTX) - Accounting Value per Share|Book Price of a Share TLSA|Cabaletta Bio, Inc (CABA) - Net Assets per Single Share|Accounting Value of a Share Ventyx Biosciences, Inc (VTYX)|THTX: Book Value per Share|Net Asset Value per Share avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Book Value per Share|AGEN: Book Value per Share|CLYM (Climb Bio, Inc.) - Net Assets per Single Share|Accounting Value per Share Zura Bio Ltd|ATYR - Accounting Value per Share|Accounting Value of a Share Adagene Corp|Book Value per Share ImageneBio Inc (IMA)|Net Assets per Single Share shattucklabs.com (STTK)|Book Value per Share EQ|Connect Biopharma Holdings - Net Assets per Share|IMUX (Immunic Inc) - Net Assets per Single Share|Atara Biotherapeutics (ATRA) - Net Asset Value per Share|Accounting Value per Share inflarx.de IFRX|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value of a Share|ACET: Book Value per Share|Net Assets per Share CELU|Net Assets per Single Share INmune Bio, Inc. INMB|Equity per Share barinthusbio.com (BRNS)|Kezar Life Sciences, Inc. - Book Value per Share|SABS - Accounting Value per Share|Akari Therapeutics plc - Accounting Value per Share|ENLV: Book Value per Share|Net Assets per Single Share q32bio.com (QTTB)|geovax.com (GOVX) - Share Book Value|Book Value per Share Edesa Biotech|Net Assets per Single Share IBIO|CARM - Net Assets per Single Share|Share Book Value XTL Bio (XTLB)|Book Value per Share Bolt Biotherapeutics, Inc.|Accounting Value of a Share HCW Biologics, Inc. HCWB|Aptevo - Book Value per Share|AIM: Book Value per Share|Net Assets per Single Share aditxt.com ADTX|GRI (GRI Bio Corporation) - Accounting Value of a Share|Net Assets per Single Share XRTX|Accounting Value per Share reshapelifesciences.com|Book Value per Share REVB|Book Value per Share Indaptus Therapeutics Inc INDP|Accounting Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Book Value per Share AFMD (Affimed Therapeutics)|ALLK: Net Assets per Share|HOOK (hookipapharma.com) - Net Assets per Single Share|IGMS (IGM Biosciences) - Accounting Value per Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp (OCEA)|Accounting Value per Share TCBP|Book Value per Share THRD (thirdharmonicbio.com)